PTC THERAPEUTICS, INC. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2012 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Ptc Therapeutics, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2012 to Q4 2023.
  • Ptc Therapeutics, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $834M, a 24% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $834M +$162M +24% Dec 31, 2023 10-K 2024-02-29
Q4 2022 $672M +$147M +27.9% Dec 31, 2022 10-K 2024-02-29
Q4 2021 $526M +$146M +38.5% Dec 31, 2021 10-K 2023-02-21
Q4 2020 $380M +$112M +42.1% Dec 31, 2020 10-K 2022-02-22
Q4 2019 $267M +$86.7M +48% Dec 31, 2019 10-K 2021-02-25
Q4 2018 $180M +$2.85M +1.6% Dec 31, 2018 10-K 2020-03-02
Q4 2017 $178M -$5.38M -2.94% Dec 31, 2017 10-K 2019-03-01
Q4 2016 $183M +$43.4M +31.1% Dec 31, 2016 10-K 2018-03-06
Q4 2015 $140M +$16.3M +13.2% Dec 31, 2015 10-K 2017-03-16
Q4 2014 $123M +$256M Dec 31, 2014 10-K 2016-02-29
Q4 2013 -$132M -$239M -224% Dec 31, 2013 10-K 2015-03-02
Q4 2012 $107M Dec 31, 2012 10-K 2014-03-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.